AlphaFold predicted structure
GNPAT · O15228

Mean pLDDT
88.5/ 100
Confident
680 residues
Confidence breakdown
- Very high(≥ 90)74%
- Confident(70–90)18%
- Low(50–70)3%
- Very low(< 50)6%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
glyceronephosphate O-acyltransferase
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
Bilateral congenital or childhood onset cataracts
BIALLELIC, autosomal or pseudoautosomalChondrodysplasia punctata
BIALLELIC, autosomal or pseudoautosomalDDG2P
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomalLikely inborn error of metabolism
BIALLELIC, autosomal or pseudoautosomalPeroxisomal disorders
BIALLELIC, autosomal or pseudoautosomalSkeletal dysplasia
BIALLELIC, autosomal or pseudoautosomal+2 more panels — install the extension to see the full list inline on any page.
rhizomelic chondrodysplasia punctata type 2
rhizomelic chondrodysplasia punctata
neurodegenerative disease
glyceronephosphate O-acyltransferase deficiency
Alzheimer disease
Parkinson disease
lysosomal storage disease
multiple sclerosis
preeclampsia
hereditary disease
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Dihydroxyacetone phosphate acyltransferase
Dihydroxyacetonephosphate acyltransferase catalyzing the first step in the biosynthesis of plasmalogens, a subset of phospholipids that differ from other glycerolipids by having an alkyl chain attached through a vinyl ether linkage at the sn-1 position of the glycerol backbone, and which unique physical properties have an impact on various aspects of cell signaling and membrane biology
GNPAT · O15228

Mean pLDDT
88.5/ 100
Confident
680 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0